Prevalence Rate of Adverse Drug Reactions from Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study

<b>Background/Objectives</b>: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are widely used in type 2 diabetes mellitus for glycemic control and cardiovascular–renal protection, but adverse effects such as acute kidney injury (AKI), urinary tract infection (UTI), euglycemic diabetic ketoacidosis...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Pichitra Srimaya, Tossapol Warong, Sudarat Kingdang, Titawadee Pradubkham, Wiraphol Phimarn
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2025-12-01
Schriftenreihe:	Pharmacoepidemiology
Schlagworte:	sodium-glucose cotransporter-2 inhibitors acute kidney injury urinary tract infection diabetic ketoacidosis pancreatitis type 2 diabetes mellitus
Online-Zugang:	https://www.mdpi.com/2813-0618/5/1/2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!